Coley's toxins in perspective
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [5]
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Goetz, F. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.09.008 · Cited by 301
Berendt, M. J., North, R. J., & Kirstein, D. P. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.6.1560 · Cited by 84
Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population
Sadeghi, S. B., Sadeghi, A., & Robboy, S. J. (1988) · Cancer · doi:10.1002/1097-0142(19880601)61:11<2219::aid-cncr2820611116>3.0.co;2-d · Cited by 58
Demetri, G. D., Spriggs, D. R., Sherman, M., Arthur, K. A., Imamura, K., & Kufe, D. W. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1545 · Cited by 57
Remarks upon the Effects Observed in the Use of Mixed Toxins (Coley) in Certain Cases of Sarcoma
Harmer, T. W. (1914) · New England Journal of Medicine · doi:10.1056/nejm191408131710701 · Cited by 4
Research works printed but not linked: 4
- Coley, W. B. Practitioner 83, 589–613 (1909).
- Nauts, H. C. et al. Can. Res. 6, 205–216 (1946).
- Tichatschek, E. et al. Can. Immun. Immunother. 27, 278–282 (1988).
- McIntosh, J. K. et al. Can. Res. 49, 1408–1414 (1989).
Cited by
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
“The earliest case of cancer immunotherapy can be traced back to 1891, when William Coley, the father of immunotherapy, first attempted to leverage the immune system to treat cancer after noticing that mixtures of live and inactivated Streptococcus pyogenes and Serratia marcescens could cause tumor regression in sarcom…”
BackgroundPhotodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
“Over 100 years ago a surgeon from New York, William Cole”
BackgroundTumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
“The failure of TNF treatment prompted Charlie Starnes to revisit Coley's work in a 1992 Nature revie”
BackgroundSchwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“Shortly thereafter, William Coley started testing a highly contentious and sometimes lethal vaccine of live or heat-killed Streptococcus and Serratia species on terminal cancer patients, which was only later shown to yield >10-year disease-free survival in ~30%of them (60 of 210 total), representing the first intentio…”
Background
Metadata
- Authors
- Starnes, C. O.
- Affiliations
- Amgen (United States) (US)
- Corresponding author
- Starnes, Charlie O.
- Venue
- Nature
- Published
- 1992-05
- Volume
- 357
- Issue
- 6373
- Pages
- 11-12
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2005179058
- Cited by
- 284
- References
- 6
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 34 · 2023: 14 · 2022: 14 · 2021: 19 · 2020: 17 · 2019: 9 · 2018: 11 · 2017: 12 · 2016: 7 · 2015: 15 · 2014: 8 · 2013: 9 · 2012: 7
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Keywords
- Coley's toxins, TNF-α, cancer therapy, patient selection, treatment efficacy
- MeSH terms
- Bacterial Vaccines, Humans, Sarcoma, Soft Tissue Neoplasms, Tumor Necrosis Factor-alpha, History, 19th Century, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.